Correlation Between Medipharm Labs and Cardiol Therapeutics

Can any of the company-specific risk be diversified away by investing in both Medipharm Labs and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medipharm Labs and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medipharm Labs Corp and Cardiol Therapeutics Class, you can compare the effects of market volatilities on Medipharm Labs and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medipharm Labs with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medipharm Labs and Cardiol Therapeutics.

Diversification Opportunities for Medipharm Labs and Cardiol Therapeutics

-0.28

Correlation Coefficient

Medipharm Labs  Cardiol Therapeutics

Very good diversification

The 3 months correlation between Medipharm and Cardiol is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Medipharm Labs Corp and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and Medipharm Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medipharm Labs Corp are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of Medipharm Labs i.e., Medipharm Labs and Cardiol Therapeutics go up and down completely randomly.

Pair Corralation between Medipharm Labs and Cardiol Therapeutics

Assuming the 90 days trading horizon Medipharm Labs Corp is expected to generate 1.39 times more return on investment than Cardiol Therapeutics. However, Medipharm Labs is 1.39 times more volatile than Cardiol Therapeutics Class. It trades about 0.05 of its potential returns per unit of risk. Cardiol Therapeutics Class is currently generating about -0.09 per unit of risk. If you would invest  7.00  in Medipharm Labs Corp on December 4, 2024 and sell it today you would earn a total of  0.50  from holding Medipharm Labs Corp or generate 7.14% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Medipharm Labs Corp  vs.  Cardiol Therapeutics Class

Medipharm Labs Corp

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Medipharm Labs Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Medipharm Labs displayed solid returns over the last few months and may actually be approaching a breakup point.

Cardiol Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cardiol Therapeutics Class has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Medipharm Labs and Cardiol Therapeutics

The main advantage of trading using opposite Medipharm Labs and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medipharm Labs position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.

The idea behind Medipharm Labs Corp and Cardiol Therapeutics Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.